{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"92.52","upperLimit":"94.08","value":"93.3"}]}],"title":"one- year survival rate"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"84.34","upperLimit":"87.86","value":"86.1"}]}],"title":"two-year survival rate"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"11.13","upperLimit":"13.87","value":"12.5"}]}],"title":"one-year relapse rate"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"17.04","upperLimit":"21.36","value":"19.2"}]}],"title":"two-year relapse rate"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"86.13","upperLimit":"88.87","value":"87.5"}]}],"title":"one-year event free survival rate"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"64.16","upperLimit":"70.44","value":"67.3"}]}],"title":"two-year event free survival rate"}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"}],"units":"Participants"}],"description":"Survival and event-free survival curves (any event of fatality, relapse, acute or chronic GVHD) with Kaplan-Meier curves. The incidence curve for relapse - accounting for the competing risk of fatality - is plotted with step-wise curves. The R statistical software (version 2.15) was used for all time-to-event analyses, with the survival package used for survival curves, and the cmprsk package used for all competing risk curves.\n\nResults: The one-year survival rate is 93.3% (SE = 0.4%), and the two-year survival rate is 86.1% (SE = 0.9%).","dispersionType":"95% Confidence Interval","groups":[{"description":"azacitidine: 75 mg/sq m daily for 5 days\n\nlenalidomide: 10 mg p.o. daily, Days 6-21","id":"OG000","title":"5-azacytidine + Lenalidomide -> Auto Stem Cell Transplant"}],"paramType":"NUMBER","populationDescription":"The outcome measure data was collected up to one to two years post transplant.","reportingStatus":"POSTED","timeFrame":"1 year to 2 years","title":"Progression-free and Overall Survival","type":"SECONDARY","unitOfMeasure":"percentage of participants"}